These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 19275274

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.
    Meletis J, Katsandris A, Raptis SD, Mantzourani M.
    Med Sci Monit; 2010 Aug; 16(8):CS100-2. PubMed ID: 20671616
    [Abstract] [Full Text] [Related]

  • 24. Romiplostim for the treatment of primary immune thrombocytopenia.
    Janssens A.
    Expert Rev Hematol; 2012 Apr; 5(2):133-44. PubMed ID: 22475281
    [Abstract] [Full Text] [Related]

  • 25. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
    Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M.
    Lancet; 2016 Jul 02; 388(10039):45-54. PubMed ID: 27103127
    [Abstract] [Full Text] [Related]

  • 26. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP, Heddle NM, Kelton JG, Hamilton K, Wang G, Sholapur N, Carruthers J, Hsia C, Blais N, Toltl L, Hamm C, Pearson MA, Arnold DM.
    Transfusion; 2016 Jan 02; 56(1):73-9. PubMed ID: 26400824
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Romiplostim: a second-generation thrombopoietin agonist.
    Cohn CS, Bussel JB.
    Drugs Today (Barc); 2009 Mar 02; 45(3):175-88. PubMed ID: 19436840
    [Abstract] [Full Text] [Related]

  • 30. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
    Deuson R, Danese M, Mathias SD, Schoonen M, Fryzek J.
    J Med Econ; 2012 Mar 02; 15(5):956-76. PubMed ID: 22533524
    [Abstract] [Full Text] [Related]

  • 31. A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.
    Bussel JB, Buchanan GR, Nugent DJ, Gnarra DJ, Bomgaars LR, Blanchette VS, Wang YM, Nie K, Jun S.
    Blood; 2011 Jul 07; 118(1):28-36. PubMed ID: 21502541
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Platelet production bolstered with romiplostim approval.
    Morrow T.
    Manag Care; 2008 Oct 07; 17(10):49-50. PubMed ID: 18990926
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.
    Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, Jun S.
    Br J Haematol; 2013 May 07; 161(3):411-23. PubMed ID: 23432528
    [Abstract] [Full Text] [Related]

  • 39. Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.
    Neunert CE, Rose MJ.
    Blood Adv; 2019 Jun 25; 3(12):1907-1915. PubMed ID: 31239245
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.